Isha Chaturvedi*

Assistant Professor, Department of Ophthalmology, TS Mishra Medical College and Hospital, India

*Corresponding Author: Isha Chaturvedi, Assistant Professor, Department of Ophthalmology, TS Mishra Medical College and Hospital, India.

Received: May 02, 2025; Published: August 01, 2025

Abstract

Myopia or short sightedness, known to be a seemingly manageable visual problem, has become a pandemic in the last two decades and more so in the COVID and post-COVID era. According to current research, 50% of the world’s population will be myopic by year 2050, of which 10% will be contributed by high myopia [1]. Being unable to see or read clearly affects the quality of life at the individual level, and is a socio-economic burden at the societal level. This is particularly true for high myopia and pathological myopia, which is associated with potentially blinding complications like cataract, glaucoma, maculopathy, retinal degenerations, posterior staphyloma, retinal detachment, choroidal neovascularization, and so on [2].

References

1. Holden BA., et al. “Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050”. Ophthalmology 123 (2016): 1036-1042.
2. Padmaja S., et al. “IMI impact of myopia”. Investigative Ophthalmology and Visual Science4 (2021).
3. Walline JJ., et al. “Interventions to slow progression of myopia in children”. Cochrane Database System Review 1 (2011): CD004916.
4. Huang J., et al. “Efficacy comparison of 16 interventions for myopia control in children: A network meta analysis”. Ophthalmology 123 (2016): 697-708.
5. Chia A., et al. “Five year clinical trial on atropine for the treatment of myopia 2: Myopia control with atropine 0.01% eyedrops”. Ophthalmology 123 (2016): 391-399.
6. Yam JC., et al. “Low concentration atropine for myopia progression (LAMP) study: A randomized, double blinded, placebo controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control”. Ophthalmology 126 (2019): 113-124.

Citation

Citation: Isha Chaturvedi. “Atropine Eye Drops in Myopia".Acta Scientific Ophthalmology 8.9 (2025): 01-02.

Copyright

Copyright: © 2025 Isha Chaturvedi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.